Skip to main content
Year archive

TELCON RF PHARMACEUTICAL. Inc. — 2023 filings

All 35 regulatory filings released by TELCON RF PHARMACEUTICAL. Inc. (200230) in 2023, sourced directly from the official regulator.

35 Filings
2023 Period
2023 filings (35)
Filing Released Lang
증권발행결과(자율공시)
Share Issue/Capital Change
2023-12-27 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2023-12-26 Korean
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings
2023-12-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-15 Korean
전환청구권행사
Share Issue/Capital Change
2023-12-06 Korean
전환청구권행사
Share Issue/Capital Change
2023-12-05 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
전환가액의조정
Capital/Financing Update
2023-10-31 Korean
전환가액의조정
Capital/Financing Update
2023-10-04 Korean
전환가액의조정
Share Issue/Capital Change
2023-08-31 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
전환가액의조정
Capital/Financing Update
2023-07-31 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-07-07 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-29 Korean
[기재정정]사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-29 Korean
단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings
2023-03-22 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-21 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-21 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-16 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2023-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-03-10 Korean
전환청구권행사
Share Issue/Capital Change
2023-02-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-02-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-02-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-02-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-02-03 Korean
투자판단관련주요경영사항(COVID-19 치료제 Lenzilumab의 식약처 임상(제1상)시험 결과)
Legal Proceedings Report
2023-02-03 Korean
[기재정정]투자판단관련주요경영사항(게실증 치료제 아시아 판권 계약 해지)
M&A Activity
2023-01-10 Korean
기타주요경영사항(게실증 치료제 아시아 판권 계약 해지)
M&A Activity
2023-01-10 Korean
전환가액의조정
Share Issue/Capital Change
2023-01-02 Korean